These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253 [TBL] [Abstract][Full Text] [Related]
4. Teaching NeuroImages: Reversible neuroimaging findings during treatment of infantile spasms with vigabatrin. Kim DD; Sharma AK; Sharma M; Andrade A Neurology; 2020 Oct; 95(16):e2314-e2315. PubMed ID: 32675075 [No Abstract] [Full Text] [Related]
5. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms. Schonstedt V; Stecher X; Venegas V; Silva C Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928 [TBL] [Abstract][Full Text] [Related]
6. Reversible MRI Changes in an Infant with Epileptic Spasms on Low Dose Vigabatrin. Jain P; Alwadhi R; Kumar V Indian J Pediatr; 2016 Sep; 83(9):1049-50. PubMed ID: 26817464 [No Abstract] [Full Text] [Related]
7. Brain MRI findings with vigabatrin therapy: case report and literature review. Hussain K; Walsh TJ; Chazen JL Clin Imaging; 2016; 40(1):180-2. PubMed ID: 26526789 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414 [TBL] [Abstract][Full Text] [Related]
9. [Reversible alterations in the neuroimages associated with vigabatrine treatment in infants with epileptic spasms]. Fernandez-Garcia MA; Garcia-Penas JJ; Gomez-Martin H; Perez-Sebastian I; Garcia-Esparza E; Sirvent-Cerda S Rev Neurol; 2017 Feb; 64(4):169-174. PubMed ID: 28169412 [TBL] [Abstract][Full Text] [Related]
10. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex. Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562 [TBL] [Abstract][Full Text] [Related]
11. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722 [TBL] [Abstract][Full Text] [Related]
12. Seizure outcome in infantile spasms--a retrospective study. Mohamed BP; Scott RC; Desai N; Gutta P; Patil S Epilepsia; 2011 Apr; 52(4):746-52. PubMed ID: 21320111 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients. Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP; Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190 [TBL] [Abstract][Full Text] [Related]
16. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective. Ibrahim S; Gulab S; Ishaque S; Saleem T BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871 [TBL] [Abstract][Full Text] [Related]
17. Vigabatrin administration in patients with infantile spasms: the risks. Jaseja H Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study. Ohtsuka Y Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579 [TBL] [Abstract][Full Text] [Related]
19. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience. Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595 [TBL] [Abstract][Full Text] [Related]
20. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures. Yum MS; Lee EH; Ko TS J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]